Aethlon Medical (AEMD) Total Debt Growth (1y) (2012 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 37.55% |
| Dec 31, 2022 | 46.04% |
| Sep 30, 2022 | 32.28% |
| Jun 30, 2022 | 35.51% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -1.04% |
| Sep 30, 2021 | -14.47% |
| Jun 30, 2021 | -9.30% |
| Mar 31, 2021 | 39.42% |
| Dec 31, 2020 | 18.46% |
| Sep 30, 2020 | 54.65% |
| Jun 30, 2020 | 39.60% |
| Mar 31, 2020 | 33.53% |
| Dec 31, 2019 | 59.44% |
| Sep 30, 2019 | 2.63% |
| Jun 30, 2019 | 4.51% |
| Mar 31, 2019 | -7.43% |
| Dec 31, 2018 | 8.20% |
| Sep 30, 2018 | 103.36% |
| Jun 30, 2018 | 86.84% |
| Mar 31, 2018 | 56.16% |
| Dec 31, 2017 | 10.46% |
| Sep 30, 2017 | -16.70% |
| Jun 30, 2017 | 71.21% |
| Mar 31, 2017 | -60.12% |
| Dec 31, 2016 | -62.37% |
| Sep 30, 2016 | -71.41% |
| Jun 30, 2016 | -83.87% |
| Mar 31, 2016 | -0.68% |
| Dec 31, 2015 | -80.86% |
| Jun 30, 2015 | -78.59% |
| Mar 31, 2015 | -98.63% |
| Dec 31, 2014 | 3.29% |
| Jun 30, 2014 | 2.42% |
| Mar 31, 2014 | 197.61% |
| Dec 31, 2013 | 6.88% |
| Sep 30, 2013 | 83.59% |
| Jun 30, 2013 | -72.21% |
| Mar 31, 2013 | 391.49% |
| Dec 31, 2012 | 18.86% |
| Sep 30, 2012 | 417.25% |
| Jun 30, 2012 | 29.41% |
| Mar 31, 2012 | -63.55% |